The BioPraxis Group strategy is based on four main elements:
Praxis Pharmaceutical markets drug products that have already been developed by other companies, and which may offer health improvements for different groups of patients. They conduct this activity in Spain, Portugal, France, Colombia, Brazil and Venezuela. Alliances
Praxis Manufacture possesses the infrastructure and staff required to produce different pharmaceutical products, including those of biological origin. Praxis Manufacture
Praxis Institute possesses the infrastructure and staff required to research and develop proprietary drugs or to acquire drugs from other research companies in different development phases. Praxis Institute
This concept encompasses a series of clinics specialized in the treatment of complex lesions. The clinics are located in various South American countries. The first clinics were opened in Colombia and Venezuela, to be followed by Brazil, Mexico, the European Union, Switzerland and Turkey. Praxis Clinic